Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 76

1.

Intracellular galectin-7 expression in cancer cells results from an autocrine transcriptional mechanism and endocytosis of extracellular galectin-7.

Bibens-Laulan N, St-Pierre Y.

PLoS One. 2017 Nov 8;12(11):e0187194. doi: 10.1371/journal.pone.0187194. eCollection 2017.

2.

Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment.

Higareda-Almaraz JC, Ruiz-Moreno JS, Klimentova J, Barbieri D, Salvador-Gallego R, Ly R, Valtierra-Gutierrez IA, Dinsart C, Rabinovich GA, Stulik J, Rösl F, Rincon-Orozco B.

BMC Cancer. 2016 Aug 24;16:680. doi: 10.1186/s12885-016-2700-8.

3.

Galectin-7 in the stratum corneum: a biomarker of the skin barrier function.

Niiyama S, Yoshino T, Yasuda C, Yu X, Izumi R, Ishiwatari S, Matsukuma S, Mukai H.

Int J Cosmet Sci. 2016 Oct;38(5):487-95. doi: 10.1111/ics.12326. Epub 2016 May 27.

PMID:
27028525
4.

Galectin-7 Regulates Keratinocyte Proliferation and Differentiation through JNK-miR-203-p63 Signaling.

Chen HL, Chiang PC, Lo CH, Lo YH, Hsu DK, Chen HY, Liu FT.

J Invest Dermatol. 2016 Jan;136(1):182-191. doi: 10.1038/JID.2015.366.

5.

Design of a peptidic inhibitor that targets the dimer interface of a prototypic galectin.

Vladoiu MC, Labrie M, Létourneau M, Egesborg P, Gagné D, Billard É, Grosset AA, Doucet N, Chatenet D, St-Pierre Y.

Oncotarget. 2015 Dec 1;6(38):40970-80. doi: 10.18632/oncotarget.5403.

6.

A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer.

Labrie M, Vladoiu M, Leclerc BG, Grosset AA, Gaboury L, Stagg J, St-Pierre Y.

PLoS One. 2015 Jul 13;10(7):e0131307. doi: 10.1371/journal.pone.0131307. eCollection 2015.

7.

Structural basis of multivalent galactose-based dendrimer recognition by human galectin-7.

Ramaswamy S, Sleiman MH, Masuyer G, Arbez-Gindre C, Micha-Screttas M, Calogeropoulou T, Steele BR, Acharya KR.

FEBS J. 2015 Jan;282(2):372-87. doi: 10.1111/febs.13140. Epub 2014 Nov 24.

8.

Expression and functions of galectin-7 in ovarian cancer.

Labrie M, Vladoiu MC, Grosset AA, Gaboury L, St-Pierre Y.

Oncotarget. 2014 Sep 15;5(17):7705-21.

9.

In vitro amyloidogenic peptides of galectin-7: possible mechanism of amyloidogenesis of primary localized cutaneous amyloidosis.

Ono K, Fujimoto E, Fujimoto N, Akiyama M, Satoh T, Maeda H, Fujii N, Tajima S.

J Biol Chem. 2014 Oct 17;289(42):29195-207. doi: 10.1074/jbc.M114.592998. Epub 2014 Aug 29.

10.

Galectin-7 is important for normal uterine repair following menstruation.

Evans J, Yap J, Gamage T, Salamonsen L, Dimitriadis E, Menkhorst E.

Mol Hum Reprod. 2014 Aug;20(8):787-98. doi: 10.1093/molehr/gau032. Epub 2014 Apr 29.

PMID:
24782449
11.

Galectin-7 acts as an adhesion molecule during implantation and increased expression is associated with miscarriage.

Menkhorst EM, Gamage T, Cuman C, Kaitu'u-Lino TJ, Tong S, Dimitriadis E.

Placenta. 2014 Mar;35(3):195-201. doi: 10.1016/j.placenta.2014.01.004. Epub 2014 Jan 24.

PMID:
24522232
12.

Galectin-7 as a potential predictive marker of chemo- and/or radio-therapy resistance in oral squamous cell carcinoma.

Matsukawa S, Morita K, Negishi A, Harada H, Nakajima Y, Shimamoto H, Tomioka H, Tanaka K, Ono M, Yamada T, Omura K.

Cancer Med. 2014 Apr;3(2):349-61. doi: 10.1002/cam4.195. Epub 2014 Feb 7.

13.

Galectin-7, induced by cis-urocanic acid and ultraviolet B irradiation, down-modulates cytokine production by T lymphocytes.

Yamaguchi T, Hiromasa K, Kabashima-Kubo R, Yoshioka M, Nakamura M.

Exp Dermatol. 2013 Dec;22(12):840-2. doi: 10.1111/exd.12268.

PMID:
24134186
14.

Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer.

Kim SJ, Hwang JA, Ro JY, Lee YS, Chun KH.

Oncotarget. 2013 Sep;4(9):1461-71.

15.

Clinical significance of galectin-7 in epithelial ovarian cancer.

Kim HJ, Jeon HK, Lee JK, Sung CO, Do IG, Choi CH, Kim TJ, Kim BG, Bae DS, Lee JW.

Anticancer Res. 2013 Apr;33(4):1555-61.

PMID:
23564797
16.

Decreased tissue and serum expression of galectin-7 in patients with hypertrophic scars.

Cho SB, Kim JS, Zheng Z, Choi MJ, Choi IG, Oh HS, Ahn KJ.

Acta Derm Venereol. 2013 Nov;93(6):669-73. doi: 10.2340/00015555-1583.

17.

Lactose binding to human galectin-7 (p53-induced gene 1) induces long-range effects through the protein resulting in increased dimer stability and evidence for positive cooperativity.

Ermakova E, Miller MC, Nesmelova IV, López-Merino L, Berbís MA, Nesmelov Y, Tkachev YV, Lagartera L, Daragan VA, André S, Cañada FJ, Jiménez-Barbero J, Solís D, Gabius HJ, Mayo KH.

Glycobiology. 2013 May;23(5):508-23. doi: 10.1093/glycob/cwt005. Epub 2013 Jan 31.

18.

Galectin-7 as a marker of cholesteatoma residue and its detection during surgery by an immunofluorescent method--a preliminary study.

Takagi D, Hato N, Okada M, Hakuba N, Gyo K, Shigemoto K, Toda T, Ogasawara M, Kameda K.

Otol Neurotol. 2012 Apr;33(3):396-9. doi: 10.1097/MAO.0b013e3182488021.

PMID:
22377647
19.

Inhibition mechanism of human galectin-7 by a novel galactose-benzylphosphate inhibitor.

Masuyer G, Jabeen T, Öberg CT, Leffler H, Nilsson UJ, Acharya KR.

FEBS J. 2012 Jan;279(2):193-202. doi: 10.1111/j.1742-4658.2011.08414.x. Epub 2011 Nov 30.

20.

Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis.

Zhu X, Ding M, Yu ML, Feng MX, Tan LJ, Zhao FK.

BMC Cancer. 2010 Jun 15;10:290. doi: 10.1186/1471-2407-10-290.

Supplemental Content

Support Center